Clinical Trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis

Name: A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis — clinical trial record (NCT06981091)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out if XH-S004 can reduce pulmanary exacerbation over a 24-week treatment duration in participants with non-cystic fibrosis bronchiectasis.

Trial Details

NCT Number	NCT06981091
Lead Sponsor	S-INFINITY Pharmaceuticals Co., Ltd
Conditions	Non-Cystic Fibrosis Bronchiectasis
Enrollment	231 participants
Start Date	2025-05-16
Primary Completion	2027-01-08 (estimated)
Study Completion	2027-04-28 (estimated)
Updated on ClinicalTrials.gov	2025-05-20